Wedbush: 'We believe CRM is a clear 2nd derivative beneficiary of the AI Revolution'
Tweet Send to a Friend
Wedbush analyst Daniel Ives reiterated an Outperform rating and $425.00 price target on salesforce.com (NYSE: CRM).The analyst commented: "With the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
